The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Targeted gene silencing in vivo by platelet membrane–coated metal-organic framework nanoparticles
Open accessAbstract
Platelet-mimicking nanoparticles enable the targeted delivery of small interfering RNA to tumors for anticancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,538
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Self-citationCell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Self-citationNanoparticle biointerfacing by platelet membrane cloaking
Hu, C.-M. J., Fang, R. H., Wang, K.-C., Luk, B. T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C. H., Kroll, A. V., et al. (2015) · Nature · doi:10.1038/nature15373 · Cited by 1,789
Self-citationEndosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Self-citationBiomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules
Liang, K., Ricco, R., Doherty, C. M., Styles, M. J., Bell, S., Kirby, N., Mudie, S., Haylock, D., Hill, A. J., Doonan, C. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8240 · Cited by 1,496
Gene silencing in mammals by small interfering RNAs
McManus, M. T., & Sharp, P. A. (2002) · Nature Reviews Genetics · doi:10.1038/nrg908 · Cited by 1,399
The promises and pitfalls of RNA-interference-based therapeutics
Castanotto, D., & Rossi, J. J. (2009) · Nature · doi:10.1038/nature07758 · Cited by 1,221
Endocytosis and exocytosis of nanoparticles in mammalian cells
Park, J. H., & Oh, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s26592 · Cited by 1,176
Unlocking the potential of the human genome with RNA interference
Hannon, G. J., & Rossi, J. J. (2004) · Nature · doi:10.1038/nature02870 · Cited by 1,064
Zhang, Q., Dehaini, D., Zhang, Y., Zhou, J., Chen, X., Zhang, L., Fang, R. H., Gao, W., & Zhang, L. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0254-4 · Cited by 958
Self-citationsiRNAs: applications in functional genomics and potential as therapeutics
Dorsett, Y., & Tuschl, T. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1345 · Cited by 909
Zhuang, J., Kuo, C.-H., Chou, L.-Y., Liu, D.-Y., Weerapana, E., & Tsung, C.-K. (2014) · ACS Nano · doi:10.1021/nn406590q · Cited by 873
Self-citationKnocking down disease: a progress report on siRNA therapeutics
Wittrup, A., & Lieberman, J. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3978 · Cited by 804
Shieh, F.-K., Wang, S.-C., Yen, C.-I., Wu, C.-C., Dutta, S., Chou, L.-Y., Morabito, J. V., Hu, P., Hsu, M.-H., Wu, K. C.-W., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/ja513058h · Cited by 774
Role of platelets and platelet receptors in cancer metastasis
Schlesinger, M. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0669-2 · Cited by 690
Breaking down the barriers: siRNA delivery and endosome escape
Dominska, M., & Dykxhoorn, D. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.066399 · Cited by 630
Anticancer Platelet‐Mimicking Nanovehicles
Hu, Q., Sun, W., Qian, C., Wang, C., Bomba, H. N., & Gu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201503323 · Cited by 630
The RNA-induced Silencing Complex: A Versatile Gene-silencing Machine
Pratt, A. J., & MacRae, I. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r900012200 · Cited by 602
Thamphiwatana, S., Angsantikul, P., Escajadillo, T., Zhang, Q., Olson, J., Luk, B. T., Zhang, S., Fang, R. H., Gao, W., Nizet, V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714267114 · Cited by 563
Self-citationAlsaiari, S. K., Patil, S., Alyami, M., Alamoudi, K. O., Aleisa, F. A., Merzaban, J. S., Li, M., & Khashab, N. M. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b11754 · Cited by 517
Li, W., Ma, H., Zhang, J., Zhu, L., Wang, C., & Yang, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-14364-2 · Cited by 454
Recent progress in development of siRNA delivery vehicles for cancer therapy
Kim, H. J., Kim, A., Miyata, K., & Kataoka, K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.011 · Cited by 424
Shielding against Unfolding by Embedding Enzymes in Metal–Organic Frameworks via a de Novo Approach
Liao, F.-S., Lo, W.-S., Hsu, Y.-S., Wu, C.-C., Wang, S.-C., Shieh, F.-K., Morabito, J. V., Chou, L.-Y., Wu, K. C.-W., & Tsung, C.-K. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b01794 · Cited by 382
Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles
Luk, B. T., Jack Hu, C.-M., Fang, R. H., Dehaini, D., Carpenter, C., Gao, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr06371b · Cited by 375
Self-citationCD24, a Mucin-Type Glycoprotein, Is a Ligand for P-Selectin on Human Tumor Cells
Aigner, S., Sthoeger, Z. M., Fogel, M., Weber, E., Zarn, J., Ruppert, M., Zeller, Y., Vestweber, D., Stahel, R., Sammar, M., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3385 · Cited by 325
Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics
Lorenzer, C., Dirin, M., Winkler, A.-M., Baumann, V., & Winkler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.003 · Cited by 284 · cited 1×
“To address this, a number of different strategies can be used to decrease nonspecific interactions while improving targeting efficiency (11).”
BackgroundWang, Z., Fu, Y., Kang, Z., Liu, X., Chen, N., Wang, Q., Tu, Y., Wang, L., Song, S., Ling, D., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b07895 · Cited by 253
Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus
Hu, Q., Qian, C., Sun, W., Wang, J., Chen, Z., Bomba, H. N., Xin, H., Shen, Q., & Gu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201603463 · Cited by 240
Altieri, D. C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.03.005 · Cited by 178
Integration of Biomolecules with Metal–Organic Frameworks
Zhuang, J., Young, A. P., & Tsung, C. (2017) · Small · doi:10.1002/smll.201700880 · Cited by 176
Self-citationSurvivin expression and targeting in breast cancer
Jha, K., Shukla, M., & Pandey, M. (2012) · Surgical Oncology · doi:10.1016/j.suronc.2011.01.001 · Cited by 162
Strategies for In Vivo Delivery of siRNAs: Recent Progress
Higuchi, Y., Kawakami, S., & Hashida, M. (2010) · BioDrugs · doi:10.2165/11534450-000000000-00000 · Cited by 127
Zhang, H., Chen, W., Gong, K., & Chen, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b09583 · Cited by 116
Amo, L., Tamayo-Orbegozo, E., Maruri, N., Eguizábal, C., Zenarruzabeitia, O., n, M. R., Arrieta, A., Santos, S. D. M., Monge, J., Vesga, M. Á., et al. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00245 · Cited by 73
Cited by
The Current Status of MOF and COF Applications
Freund, R., Zaremba, O., Arnauts, G., Ameloot, R., Skorupskii, G., Dincă, M., Bavykina, A., Gascon, J., Ejsmont, A., Goscianska, J., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202106259 · Cited by 1,194
Targeting drugs to tumours using cell membrane-coated nanoparticles
Fang, R. H., Gao, W., & Zhang, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00699-x · Cited by 980
Self-citationMetal–Organic Frameworks for Drug Delivery: A Design Perspective
Lawson, H. D., Walton, S. P., & Chan, C. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c01089 · Cited by 916
Lipids and Lipid Derivatives for RNA Delivery
Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 626
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Metadata
- Authors
- Zhuang, J., Gong, H., Zhou, J., Zhang, Q., Gao, W., Fang, R. H., & Zhang, L.
- Venue
- Science Advances
- Published
- 2020-03-27
- Volume
- 6
- Issue
- 13
- Pages
- eaaz6108-eaaz6108
- ISSN
- 2375-2548 (ISSN-L)
- OpenAlex
- W3013635432
- Cited by
- 363
- References
- 39
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.